Skip to main content
. 2022 Nov 5;22:411. doi: 10.1186/s12883-022-02930-9

Table 1.

Baseline Patient Characteristics

Resection (n = 60) Biopsy (n = 45) P-value
Median age/y 59 (17–76) 64 (29–89) P = .004
Gender(male/female) 30/30 27/18 P = .309
Median KPS 70(30–90) 70(30–100) P = .040
Maximum dimension
  < 3 cm 11(19.0%) 16(36.4%) P = .084
  ≥ 3 cm 40(69.0%) 27(61.4%)
Location
  Deep 23(38.3%) 34(75.6%) P < 0.001
  Superficial 37(61.7%) 11(24.4%)
Radiation therapy
  Yes 33(55.0%) 21(46.7%) P = .239
  No 18(30.0%) 19(42.2%)
Chemotherapy
  Yes 32(53.3%) 34(75.6%) P = .002
  No 14(23.3%) 1(2.2%)
Median PFS/m 29.27 44.03 P = .567
Median OS/m 64.17 59.93 P = .883
Survival rate 46.7% 55.6% P = .367

Abbreviation: PFS, progression-free survival, OS  overall survival, KPS Karnofsky performance status;